Nasdaq ardx

Ardelyx Inc (NASDAQ:ARDX) Real-Time Quotes. 4.55. BATS BZX Real-Time Price. As of 10:35am ET. +0.19 / +4.36%. Today’s Change. 1.67. .

31 thg 8, 2023 ... The average one-year price target for Ardelyx (NASDAQ:ARDX) has been revised to 8.59 / share. This is an increase of 18.82% from the prior ...View Ardelyx, Inc ARDX investment & stock information. Get the latest Ardelyx, Inc ARDX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... NASDAQ data is at least 15 ...

Did you know?

Private Advisor Group LLC bought a new stake in shares of Ardelyx, Inc. ( NASDAQ:ARDX – Free Report) during the 2nd quarter, according to its most recent 13F …Stock analysis for Ardelyx Inc (ARDX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Private Advisor Group LLC bought a new stake in shares of Ardelyx, Inc. ( NASDAQ:ARDX – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and ...ARDX Ardelyx Options Ahead of Earnings If you haven`t bought ARDS before it went up 6X: Then analyzing the options chain and the chart patterns of ARDX Ardelyx prior to the earnings report this week, I would consider purchasing the 4usd strike price Calls with an expiration date of 2024-1-19, for a premium of approximately $0.45.

Complete Ardelyx Inc. stock information by Barron's. View real-time ARDX stock price and news, along with industry-best analysis. Ardelyx, Inc. (NASDAQ:ARDX) Q3 2023 Earnings Call Transcript (Insider Monkey) Oct-31-23 11:15PM Q3 2023 Ardelyx Inc Earnings Call (Thomson Reuters StreetEvents) +9.12%. 05:09PM Why Ardelyx Stock Soared Today (Motley Fool) 08:40AM Ardelyx (ARDX) Q3 Earnings and Revenues Top Estimates ...Ardelyx (NASDAQ: ARDX) is a biotechnology company that creates medicines for currently unmet medical needs. ARDX stock is up 34.33% YTD. Analysts rate the stock from a “buy” to a “strong buy ...See the latest Ardelyx Inc stock price (ARDX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Ardelyx (NASDAQ: ARDX) is a biotechnology company that creates medicines for currently unmet medical needs. ARDX stock is up 34.33% YTD. Analysts rate the stock from a “buy” to a “strong buy ...

A total of 14 hedge funds in Insider Monkey’s database of hedge funds had stakes in Ardelyx Inc. (NASDAQ:ARDX). The most significant stake in Ardelyx Inc. (NASDAQ:ARDX) was owned by. 6.Ardelyx (NASDAQ: ARDX) is a biotechnology company that focuses on developing novel therapies for unmet medical needs. The company’s growth and potential breakthroughs in medical treatments could ...After Hours Volume: 64.24K. Close. Chg. Chg %. $4.3300. 0.3000. 7.44%. Ardelyx Inc. advanced stock charts by MarketWatch. View ARDX historial stock data and compare to other stocks and exchanges. ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Nasdaq ardx. Possible cause: Not clear nasdaq ardx.

WALTHAM, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...After Hours Volume: 64.24K. Close. Chg. Chg %. $4.3300. 0.3000. 7.44%. Ardelyx Inc. advanced stock charts by MarketWatch. View ARDX historial stock data and compare to other stocks and exchanges.Ardelyx, Inc. Common Stock (ARDX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Ardelyx Inc (NASDAQ:ARDX) trade information. Upright in the red during last session for losing -0.39%, in the last five days ARDX remained trading in the green while hitting it’s week-highest on Wednesday, 11/15/23 when the stock touched $3.86 price level, adding 6.76% to its value on the day.WALTHAM, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...

apply for options webull Nov 16, 2023 · Ardelyx Inc (NASDAQ:ARDX) showed a performance of -1.41% in past 30-days. Number of shares sold short was 36.47 million shares which calculate 4.09 days to cover the short interests. Wall Street analysts have assigned a consensus price target of $9.64 to the stock, which implies a rise of 59.96% to its recent value today. 1979 one dollar coinsshyg etf 730% upside stock according to Citigroup Ardelyx , Inc. ARDX had one of the the highest the out of the money call options, due to the fact they plan to launch IBSRELA, the …Ardelyx (ARDX) Company Description: Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of renal diseases. us options brokers 13.89. 970.71 · Barron's 400. 21.63. 1009.51 · Market Data; /; Stocks; /; ARDX; /; Financials. Ardelyx Inc. U.S.: Nasdaq. Watchlist. after hours. $ 4.9400. ARDX.Health care stocks were finishing near their Friday highs this afternoon, with the NYSE Health Care Index rising 1.0% while the Health Care Select Sector SPDR Fund (XLV) was up 0.9%. 1stdibs stockbest ia stockdoordash weed Ardelyx (NASDAQ: ARDX) is a biotechnology company that creates medicines for currently unmet medical needs. ARDX stock is up 34.33% YTD. Analysts rate the stock from a “buy” to a “strong buy ... groy stock forecast Ardelyx Inc stock price (ARDX). NASDAQ: ARDX. Buying or selling a stock that's not traded in your local currency? Don't let the currency conversion trip you ...NVIDIA Corporation Common Stock. $439.77 -0.64 -0.15%. VFS. VinFast Auto Ltd. Ordinary Shares. $8.11 +0.06 +0.75%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours ... walmart chenmedtop hft companiesvanguard federal money market Find real-time ARDX - Ardelyx Inc stock quotes, company profile, news and forecasts from CNN Business. ... Ardelyx Inc (NASDAQ:ARDX) Real-Time Quotes. 4.55. BATS BZX Real-Time Price. As of 10:35am ETWALTHAM, Mass., May 01, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...